Susquehanna International Group, LLP Fibrogen Inc Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Fibrogen Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 483,100 shares of FGEN stock, worth $188,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
483,100
Previous 144,300
234.79%
Holding current value
$188,409
Previous $339,000
26.55%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding FGEN
# of Institutions
115Shares Held
57.5MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$5.33 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$3.49 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.31 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$939,7630.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $36.6M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...